XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income $ 22,922 $ 21,458
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 4,155 3,235
Net amortization of premiums on securities 1,052 1,350
Provision for loan losses 3,547 2,989
Share-based compensation 635 759
Deferred income tax expense (benefit) 680 (4,978)
Proceeds from sale of loans held for sale 15,432 9,766
Originations of loans held for sale (14,163) (8,835)
Income on company owned life insurance (834) (893)
Net gain on sale of loans held for sale (589) (227)
Net gain on investment securities (113) (7)
Net gain on other assets (58) (12)
(Increase) decrease in other assets (2,786) 6,785
Decrease in other liabilities (747) (1,122)
Net cash provided by operating activities 29,133 30,268
Cash flows from investing activities:    
Purchases of available for sale securities (20,932)  
Purchases of held to maturity securities (7,494) (16,535)
Proceeds from principal payments, maturities and calls on available for sale securities 40,119 14,813
Proceeds from principal payments, maturities and calls on held to maturity securities 54,735 59,448
Proceeds from sales of securities available for sale 44,615 5,768
Net loan originations (88,993) (169,315)
Loans sold to others 21,077  
Purchases of company owned life insurance, net of proceeds received (24) (7)
Proceeds from sales of other assets 329 259
Purchases of premises and equipment (1,684) (1,102)
Cash consideration paid for acquisition, net of cash acquired   (4,447)
Net cash provided by (used in) investing activities 41,748 (111,118)
Cash flows from financing activities:    
Net increase in deposits 105,082 51,993
Net (decrease) increase in short-term borrowings (161,000) 26,600
Purchases of common stock for treasury (193) (113)
Proceeds from stock options exercised   309
Cash dividends paid to common and preferred shareholders (8,537) (8,040)
Net cash (used in) provided by financing activities (64,648) 70,749
Net increase (decrease) in cash and cash equivalents 6,233 (10,101)
Cash and cash equivalents, beginning of period 102,755 99,195
Cash and cash equivalents, end of period $ 108,988 $ 89,094